NEW YORK, March 13, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Rocket Lab USA, Inc. (NASDAQ: RKLB).Shareholders who purchased shares of RKLB during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/rocket-lab-usa-inc-loss-submission-form/?id=135496&from=4CLASS PERIOD: November 12, ...

Company Overview - Defiance ETFs has launched two 2X leveraged single-stock ETFs, RKLX and HIMZ, aimed at providing amplified exposure to Rocket Lab USA, Inc. (NASDAQ: RKLB) and Hims & Hers Health Inc. (NYSE: HIMS) [1][2] - These ETFs allow traders to seek enhanced returns on Rocket Lab and Hims & Hers without the need for a margin account [1][2] Industry Insights - Rocket Lab is positioned in the satellite technology sector, focusing on satellite launches, space exploration, and advanced aerospace systems [8] - Hims & Hers operates in the digital healthcare sector, pioneering telehealth and direct-to-consumer healthcare solutions [8] - Both companies are noted for driving innovation in their respective industries, with increasing demand for their services [2] Investment Strategy - RKLX seeks daily investment results that correspond to twice (200%) the daily percentage change of Rocket Lab [8] - HIMZ aims for daily investment results that correspond to twice (200%) the daily return of Hims & Hers [8] - The funds are designed for knowledgeable investors who understand the risks associated with leveraged investments and are willing to actively manage their portfolios [2][4]

NEW YORK, March 12, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Rocket Lab USA, Inc. (“Rocket Lab” or the “Company”) (NASDAQ: RKLB) for violations of the federal securities laws on behalf of investors who purchased or acquired Rocket Lab common stock between November 12, 2024 and February 25, 2025, inclusive (the “Class Period”). On February 27, 2025, a complaint was filed again ...

Rocket Lab is buying and selling today. So are its investors.Rocket Lab (RKLB 2.86%) stock took investors on a wild ride on Wednesday. Spiking more than 11% in pre-market trading, and still up nearly 9% as the market opened, shares of the space stock have fallen steadily in the hours since. As of 11:35 a.m. ET, Rocket Lab stock remains only barely in the green -- up 0.5%.But what made Rocket Lab stock rise in the first place, and why has it given up most of its gains?Rocket Lab's good newsWe'll begin with t ...

Rocket Lab USA, Inc. (NASDAQ: RKLB ) has a jam-packed 2025 schedule filled with new launches as well as acquisitions. I'm initiating the stock with a buy. Not too big, not too small, Rocket Lab sits in a strategic positionI’m a retired Wall Street PM specializing in TMT; since kickstarting my career, I’ve spent over two decades in the market navigating the technology landscape, focusing on risk mitigation through the dot com bubble, credit default of ‘08, and, more recently, with the AI boom. In one word, w ...

NEW YORK, March 12, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Rocket Lab USA, Inc. ("Rocket Lab" or the "Company") (NASDAQ: RKLB) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Rocket Lab investors who were adversely affected by alleged securities fraud between November 12, 2024 and February 25, 2025. Follow the link below to get more information and be contacted by a member of our team:https://zlk.com/pslra-1/rocket-lab-usa-inc ...

Rockets can go up, or they can explode. Same thing for space stocks.I won't sugarcoat this for you: Last week was a pretty depressing time to be a space investor.In back-to-back developments Thursday, we learned first that an unmanned Nova-C lunar lander tried to touch down on the moon's South Pole. But it toppled over within a crater, fell on its side, and died a quiet death deprived of sunlight for its solar cells.A few hours later, the eighth flight test of the SpaceX Starship ended in a fireball when th ...

Core Viewpoint - Rocket Lab USA has shown resilience and growth in the space industry, with significant stock performance and operational achievements since its SPAC merger in 2021 [1][2]. Company Overview - Rocket Lab specializes in launching small payloads into space using its reusable orbital rocket, Electron, which has successfully launched 60 times and deployed 210 satellites [2][4]. - The company is expanding its capabilities with the upcoming Neutron rocket, which will have a maximum capacity of 15,000 kilograms, set to debut in the second half of 2025 [5]. Financial Performance - From 2021 to 2024, Rocket Lab's annual revenue increased sevenfold, with projections for continued growth [3]. - Revenue figures are as follows: $62 million in 2021, $211 million in 2022, $245 million in 2023, and projected $436 million in 2024 [4]. - Adjusted EBITDA margins, while negative, have shown improvement, with expectations of turning positive by 2026 [4][9]. Growth Catalysts - Rocket Lab has secured multiple contracts, including launching satellites for NASA and deploying a constellation for Kinéis, indicating strong demand for its services [6][8]. - The company is also involved in testing hypersonic flights, with a potential contract value of $1.45 billion over five years [8]. Future Projections - Analysts forecast Rocket Lab's revenue to grow at a compound annual growth rate (CAGR) of 42% from 2024 to 2027, reaching $1.24 billion [9]. - If the company maintains a robust growth trajectory, annual revenue could reach $5.35 billion by 2035 and potentially $21.7 billion by 2045 [11]. Valuation Insights - Rocket Lab's current enterprise value is $9.66 billion, with a valuation of 17 times this year's sales, which may appear high but is more reasonable at 8 times projected 2027 sales [10]. - A hypothetical investment of $10,000 could grow to approximately $220,000 over 20 years if the company achieves its growth targets [12].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Rocket Lab USA, Inc. regarding a class action lawsuit due to alleged misleading statements and undisclosed issues affecting the company's operations and prospects [1][2]. Group 1: Allegations - The complaint alleges that during the class period from November 12, 2024, to February 25, 2025, Rocket Lab's management made materially false and misleading statements [1]. - Specific allegations include significant delays in the company's plans for three barge landing tests and a critical potable water issue that will not be resolved until January 2026, impacting the launch pad preparation [1]. - As a result of these issues, there is a substantial risk that Rocket Lab's Neutron rocket will not launch as scheduled in mid-2025, and the only contract for Neutron was made at a discount with an unreliable partner [1]. Group 2: Next Steps for Shareholders - Shareholders who purchased shares of RKLB during the specified class period are encouraged to register for the class action by April 28, 2025, to potentially become lead plaintiffs [2]. - Once registered, shareholders will be enrolled in a portfolio monitoring software to receive updates on the case's status [2]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit, fraud, and illegal business practices [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements or omissions that inflated stock prices [3].

Rocket Lab's Neutron rocket is a really big deal. How big? Sit back and let Rocket Lab's leaders tell you all about it.Rocket Lab (RKLB 0.75%) stock tumbled ahead of earnings last week, but it's been making up ground since -- and rightly so. Rumors of rocket launch delays and wobbly stock price notwithstanding, investors should probably be pretty happy right now, after the flurry of press releases this company announced surrounding its earnings.In addition to reporting "record-setting" revenue in 2024, and ...